As cell-based therapies develop extra advanced and manufacturing networks broaden, resilience can’t be an afterthought, and cryopreservation can not simply be a step that will get validated throughout growth and left alone. It must play an ongoing position in product consistency, efficiency, and reliability.
The publish Frozen Does Not Imply Steady: Rethinking Cryopreservation in Cell and Gene Remedy Manufacturing appeared first on MedCity Information.
